Table 5.
Factors associated with postoperative neurological function and prognostic factors for recurrence.
| Demographic | Neurological function | Recurrence | ||||
|---|---|---|---|---|---|---|
| Worsened (n = 9) | Improved/stable (n = 107) | P value | Yes (n = 8) | No (n = 108) | P value | |
| Age | n.s. | 0.054 | ||||
| < 50 years | 3 (33%) | 34 (32%) | 5 (62%) | 32 (30%) | ||
| ≥ 50 years | 6 (67%) | 73 (68%) | 3 (38%) | 76 (70%) | ||
| Gender | n.s. | 0.018* | ||||
| Male | 4 (44%) | 18 (17%) | 4 (50%) | 18 (17%) | ||
| Female | 5 (56%) | 91 (83%) | 4 (50%) | 92 (83%) | ||
| Sagittal tumor location | n.s. | n.s. | ||||
| Cervical | 1 (11%) | 21 (20%) | 2 (25%) | 20 (19%) | ||
| Thoracic | 7 (77%) | 83 (77%) | 5 (63%) | 85 (79%) | ||
| Lumbar | 1 (11%) | 3 (3%) | 1 (13%) | 3 (3%) | ||
| Axial tumor location | n.s. | n.s. | ||||
| Ventral | 4 (44%) | 29 (27%) | 3 (38%) | 31 (29%) | ||
| Dorsal | 3 (33%) | 12 (11%) | 0 (0%) | 15 (14%) | ||
| Others | 2 (22%) | 66 (62%) | 5 (62%) | 62 (57%) | ||
| Dural tail | n.s. | 0.046* | ||||
| Yes | 4 (44%) | 32 (30%) | 5 (63%) | 31 (29%) | ||
| No | 5 (55%) | 75 (70%) | 3 (37%) | 77 (71%) | ||
| Symptom duration | 0.041* | n.s. | ||||
| Mean ± SD (months) | 29.7 ± 30.1 | 9.8 ± 8.0 | 13.0 ± 18.6 | 11.2 ± 11.7 | ||
| WHO classification | n.s. | n.s. | ||||
| Grade I | 6 (67%) | 107 (100%) | 5 (63%) | 108 (100%) | ||
| Grade II | 3 (33%) | 0 (0%) | 3 (37%) | 0 (0%) | ||
| Preoperative McCormick | 0.024* | n.s. | ||||
| I or II | 2 (22%) | 65 (61%) | 3 (37%) | 64 (59%) | ||
| III or IV or V | 7 (78%) | 42 (39%) | 5 (63%) | 44 (61%) | ||
| Simpson grade | n.s. | < 0.01** | ||||
| I | 2 (22%) | 27 (25%) | 0 (0%) | 29 (27%) | ||
| II | 5 (56%) | 74 (69%) | 2 (25%) | 77 (71%) | ||
| III or IV | 2 (22%) | 6 (6%) | 6 (75%) | 2 (2%) | ||
Significant difference *P < 0.05, **P < 0.01.